Related Experiment Video
Updated: Dec 23, 2025
11:23
Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
Published on: December 22, 2014
37.6K
[CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]
Nello Martini1, Carlo Piccinni1, Antonella Pedrini1
1Fondazione ReS (Ricerca e Salute), Casalecchio di Reno (Bologna).
Recenti Progressi in Medicina
|April 23, 2020
Summary
Chronic diseases and comorbidities significantly impact COVID-19 risk and outcomes. The MaCroScopio project integrates data to improve care for these vulnerable populations.
Area of Science:
- Public Health
- Epidemiology
- Health Services Research
Background:
- Chronic diseases and multimorbidity are key factors influencing COVID-19 infection risk and disease progression.
- Epidemiological data reveal varying prevalence of chronic conditions among COVID-19 patients globally, underscoring their consistent impact.
- The Italian Medicines Agency implemented measures to support chronic and frail patients during the pandemic.
Purpose of the Study:
- To integrate administrative data with COVID-19 Registers for enhanced planning and research.
- To analyze the impact of chronic conditions on COVID-19 outcomes.
- To evaluate the economic and organizational effects of the pandemic on chronic disease management.
Main Methods:
- Utilizing the MaCroScopio project (Observatory on Chronic Diseases) framework.
- Integrating administrative data flows with COVID-19 Registers.
- Analyzing epidemiological data on chronic diseases and multimorbidity in COVID-19 patients.
Main Results:
- Consistent evidence across studies highlights the significant impact of chronicity and comorbidity on COVID-19.
- Measures were taken to extend therapeutic plans and monitoring for chronic patients.
- Research initiated to integrate data for better planning and understanding of pandemic impact.
Conclusions:
- Chronicity and comorbidity are critical considerations in managing COVID-19.
- Data integration is essential for effective planning, research, and resource allocation for chronic disease populations.
- The pandemic's economic and organizational impact on chronic care requires ongoing evaluation.
More Related Videos
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.4K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.4K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.0K
01:22Chronic Obstructive Pulmonary Disease
2.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
01:18Factors Affecting Illness
4.9K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.9K